Advanced Hemorrhage Control Systems
Legal Citation
Summary of the Inventive Concept
A next-generation hemorrhage control system that leverages AI, shape-memory alloys, and micro-robotics to revolutionize the treatment of catastrophic bleeding.
Background and Problem Solved
The original patent's automated retrievable hemorrhage control system, while effective, has limitations in terms of adaptability, real-time monitoring, and multi-site bleeding control. The new inventive concept addresses these limitations by introducing advanced materials, AI-driven analytics, and swarm robotics to provide a more comprehensive and effective solution.
Detailed Description of the Inventive Concept
The advanced hemorrhage control system comprises a stent graft device with an adaptive shape-memory alloy that adjusts to the blood vessel's diameter, a neural network-based controller that predicts and prevents hemorrhage, and a real-time monitoring system that integrates AI-driven analytics with sensor data. The system also includes a swarm of micro-robots that navigate to the site of bleeding and deploy a nanofiber-based hemostatic agent, and a centralized command center that coordinates the micro-robots' actions. Additionally, the system features a modular, implantable device for controlling bleeding from multiple sites, comprising a series of interconnected stent graft modules, each with its own AI-powered flow control system, and a user interface for real-time monitoring and adjustment.
Novelty and Inventive Step
The new inventive concept introduces several novel features, including the use of adaptive shape-memory alloys, AI-driven analytics, swarm robotics, and bio-inspired, shape-shifting materials. These advancements provide a significant improvement over the original patent, enabling real-time monitoring, multi-site bleeding control, and more effective hemorrhage prevention.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept could include the use of different materials, such as hydrogels or polymers, or variations in the design of the stent graft device, such as the use of different shapes or geometries. Additionally, the system could be adapted for use in different medical contexts, such as trauma care or surgical procedures.
Potential Commercial Applications and Market
The advanced hemorrhage control system has significant commercial potential in the medical device industry, particularly in the areas of trauma care, cardiovascular surgery, and emergency medicine. The system's ability to provide real-time monitoring, multi-site bleeding control, and more effective hemorrhage prevention makes it an attractive solution for hospitals and medical centers.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61F2/958 |
| A | A61 | A61B5/02 |
| A | A61 | A61B5/02042 |
| A | A61 | A61B5/6862 |
| A | A61 | A61B17/12036 |
| A | A61 | A61B17/12045 |
| A | A61 | A61B17/12109 |
| A | A61 | A61B17/12118 |
| A | A61 | A61B17/12136 |
| A | A61 | A61F2/07 |
| A | A61 | A61B5/024 |
| A | A61 | A61B5/02055 |
| A | A61 | A61B5/02158 |
| A | A61 | A61B5/14539 |
| A | A61 | A61B5/14542 |
| A | A61 | A61B5/6853 |
| A | A61 | A61B2017/00017 |
| A | A61 | A61B2017/00022 |
| A | A61 | A61F2/9522 |
| A | A61 | A61F2002/061 |
| A | A61 | A61F2002/077 |
| A | A61 | A61F2002/9528 |
| A | A61 | A61F2230/0067 |
| A | A61 | A61F2230/0069 |
| A | A61 | A61F2250/001 |
| A | A61 | A61F2250/0002 |
| A | A61 | A61F2250/0003 |
| A | A61 | A61F2250/0024 |
| A | A61 | A61F2250/0039 |
| A | A61 | A61F2250/0059 |
| A | A61 | A61F2250/0069 |
| A | A61 | A61F2250/0096 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Medical device engineering, specifically endovascular hemorrhage control systems, involving expertise in biomedical engineering, interventional radiology, materials science, and advanced sensor technologies
Person of Ordinary Skill (PHOSITA) Profile
A biomedical engineer with advanced degrees, experienced in medical device design, familiar with vascular intervention techniques, sensor integration, and adaptive medical technologies with knowledge of materials engineering and AI-assisted medical systems
Obviousness Rationale
A PHOSITA would recognize that the PTD's proposed variations represent predictable technological extensions of the source patent's core hemorrhage control system, utilizing known engineering techniques such as adaptive materials, integrated sensors, and AI-driven monitoring to enhance existing stent graft technologies. The proposed modifications represent incremental improvements using standard design approaches within the medical device engineering domain. The combination of shape-memory alloys, neural network controllers, and modular design would be considered obvious evolutionary developments for a skilled practitioner seeking to optimize hemorrhage control systems.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,443 |
|---|---|
| Title | Automated retrievable hemorrhage control system |
| Assignee(s) | Board of Regents of the University of Nebraska |